參考文獻
1. Bates, D.W., K.E. Pruess, and T.H. Lee, How Bad Are Bacteremia and Sepsis?: Outcomes in a Cohort With Suspected Bacteremia. Archives of Internal Medicine, 1995. 155(6): p. 593-598.
2. 國家發展委員會. 中華民國人口推估 (2020 至 2070 年 ). 2020; Available from: https://www.ndc.gov.tw/en/cp.aspx?n=2E5DCB04C64512CC.
3. Laupland, K.B., et al., Burden of community-onset bloodstream infection: a population-based assessment. Epidemiol Infect, 2007. 135(6): p. 1037-42.
4. Lee, C.C., et al., Age-Related Trends in Adults with Community-Onset Bacteremia. Antimicrob Agents Chemother, 2017. 61(12).
5. Henrard, S., N. Speybroeck, and C. Hermans, Classification and regression tree analysis vs. multivariable linear and logistic regression methods as statistical tools for studying haemophilia. Haemophilia, 2015. 21(6): p. 715-22.
6. Guilamet, M.C.V., et al., Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections. Medicine (Baltimore), 2019. 98(16): p. e15276.
7. Nelson, A.N., et al., Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection, 2017. 45(5): p. 613-620.
8. Chotiprasitsakul, D., et al., Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score–Matched Cohort. Clinical Infectious Diseases, 2017. 66(2): p. 172-177.
9. Lee, C.C., et al., Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third- Generation-Cephalosporin Therapy. Antimicrob Agents Chemother, 2017. 61(2).
10. Wang, M., et al., Thresher: determining the number of clusters while removing outliers. BMC Bioinformatics, 2018. 19(1): p. 9.
11. Seifert, H., The Clinical Importance of Microbiological Findings in the Diagnosis and Management of Bloodstream Infections. Clinical Infectious Diseases, 2009. 48(Supplement_4): p. S238-S245.
12. Laupland, K.B. and D.L. Church, Population-based epidemiology and microbiology of community-onset bloodstream infections. Clin Microbiol Rev, 2014. 27(4): p. 647- 64.
13. Takeshita, N., et al., Unique characteristics of community-onset healthcare-
69 associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan. J Hosp Infect, 2017. 96(1): p. 29-34.
14. Diekema, D.J., et al., Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol, 2003. 41(8): p. 3655-60.
15. Deen, J., et al., Community-acquired bacterial bloodstream infections in developing countries in south and southeast Asia: a systematic review. Lancet Infect Dis, 2012.12(6): p. 480-7.
16. Dantes, R.B., et al., Preventability of hospital onset bacteremia and fungemia: A pilot study of a potential healthcare-associated infection outcome measure. Infect Control Hosp Epidemiol, 2019. 40(3): p. 358-361.
17. Kao, C.H., et al., Isolated pathogens and clinical outcomes of adult bacteremia in the emergency department: a retrospective study in a tertiary Referral Center. J
Microbiol Immunol Infect, 2011. 44(3): p. 215-21.
18. Mahon, C.R., Lehman, D. C., & Manuselis, G. , Textbook of diagnostic
microbiology. 6th ed. 2019: Elsevier Saunders.
19. Hongsuwan, M., et al., Increasing incidence of hospital-acquired and healthcare-associated bacteremia in northeast Thailand: a multicenter surveillance study. PLoS One, 2014. 9(10): p. e109324.
20. Hilf, M., et al., Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med, 1989. 87(5): p. 540-6.
21. Al-Hasan, M.N., et al., Predictive scoring model of mortality in Gram-negative
bloodstream infection. Clin Microbiol Infect, 2013. 19(10): p. 948-54.
22. Battle, S.E., et al., Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection. Infection, 2019. 47(4): p. 571-578.
23. Chow, J.W. and V.L. Yu, Combination antibiotic therapy versus monotherapy for
gram-negative bacteraemia: a commentary. Int J Antimicrob Agents, 1999. 11(1): p.
7-12.
24. Hill, P.C., et al., Prospective study of 424 cases of Staphylococcus aureus
bacteraemia: determination of factors affecting incidence and mortality. Intern Med J, 2001. 31(2): p. 97-103.
25. Yu, V.L., et al., An international prospective study of pneumococcal bacteremia:
correlation with in vitro resistance, antibiotics administered, and clinical outcome.
Clin Infect Dis, 2003. 37(2): p. 230-7.
26. Vaquero-Herrero, M.P., et al., The Pitt Bacteremia Score, Charlson Comorbidity
Index and Chronic Disease Score are useful tools for the prediction of mortality in patients with Candida bloodstream infection. Mycoses, 2017. 60(10): p. 676-685.
27. Henderson, H., et al., The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. 70(9): p. 1826-1833.
28. Lee, A., et al., Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol, 2007. 45(11): p. 3546-8.
29. Lee, C.C., et al., Beneficial effects of early empirical administration of appropriate antimicrobials on survival and defervescence in adults with community-onset bacteremia. Crit Care, 2019. 23(1): p. 363.
30. Liu, Y., et al., How to Read Articles That Use Machine Learning: Users’ Guides to the Medical Literature. JAMA, 2019. 322(18): p. 1806-1816.
31. Cios, K.J., et al., Unsupervised Learning: Clustering, in Data Mining: A Knowledge Discovery Approach, K.J. Cios, et al., Editors. 2007, Springer US: Boston, MA. p. 257-288.
32. Cios, K.J., et al., Unsupervised Learning: Association Rules, in Data Mining: A Knowledge Discovery Approach, K.J. Cios, et al., Editors. 2007, Springer US: Boston, MA. p. 289-306.
33. Huang, Z., Clustering large data sets with mixed numeric and categorical values. Proceedings of the First
Pacific Asia Knowledge Discovery and Data Mining Conference, Singapore: World Scientific. 1997a: p. pp. 21–34.
34. Huang, Z., Extensions to the k-Means Algorithm for Clustering Large Data Sets with Categorical Values. Data Min. Knowl. Discov., 1998. 2(3): p. 283–304.
35. Budiaji, W. and F. Leisch, Simple K-Medoids Partitioning Algorithm for Mixed Variable Data. Algorithms, 2019. 12(9): p. 177.
36. Kaufman, L.R., P.J., Finding Groups in Data. 1990, New York, NY, USA: John Wiley and Sons Inc.
37. Jenhani, I., N.B. Amor, and Z. Elouedi, Decision trees as possibilistic classifiers. International Journal of Approximate Reasoning, 2008. 48(3): p. 784-807.
38. Trivedi, S., Z.A. Pardos, and N.T. Heffernan, The utility of clustering in prediction tasks. arXiv preprint arXiv:1509.06163, 2015.
39. Kobayashi, D., et al., A predictive rule for mortality of inpatients with Staphylococcus aureus bacteraemia: A classification and regression tree analysis. Eur J Intern Med, 2014. 25(10): p. 914-8.
40. Quan, H., et al., Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care, 2005. 43(11): p. 1130-9.
41. McCABE, W.R. and G.G. JACKSON, Gram-Negative Bacteremia: II. Clinical, Laboratory, and Therapeutic Observations. Archives of Internal Medicine, 1962.110(6): p. 856-864.
42. Chen, H., P. Cohen, and S. Chen, How Big is a Big Odds Ratio? Interpreting the
Magnitudes of Odds Ratios in Epidemiological Studies. Communications in Statistics- Simulation and Computation, 2010. 39(4): p. 860-864.
43. Moore, W.C., et al., Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med, 2010. 181(4): p. 315-23.
44. Sweeney, T.E., et al., Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters. Crit Care Med, 2018.46(6): p. 915-925.
45. Zhang, Z., et al., Deep learning-based clustering robustly identified two classes of sepsis with both prognostic and predictive values. EBioMedicine, 2020. 62.
46. Yang, C.Y., et al., Differential effects of inappropriate empirical antibiotic therapy in adults with community-onset gram-positive and gram-negative aerobe bacteremia. J Infect Chemother, 2020. 26(2): p. 222-229.
47. Corl, K.A., et al., Delay in Antibiotic Administration Is Associated With Mortality
Among Septic Shock Patients With Staphylococcus aureus Bacteremia. Crit Care
Med, 2020. 48(4): p. 525-532.
48. Falcone, M., et al., Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care, 2020. 24(1): p. 29.
49. Bonine, N.G., et al., Impact of Delayed Appropriate Antibiotic Therapy on Patient Outcomes by Antibiotic Resistance Status From Serious Gram-negative Bacterial Infections. Am J Med Sci, 2019. 357(2): p. 103-110.
50. Lodise, T.P., et al., A systematic review of the association between delayed
appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long? BMC Infect Dis, 2018. 18(1): p. 625.
51. Zasowski, E.J., et al., Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections. Clin Infect Dis, 2016. 62(10): p. 1242-1250.
52. Lodise, T.P., Jr., et al., Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother, 2007. 51(10): p. 3510-5.
53. Lodise, T.P., et al., Outcomes analysis of delayed antibiotic treatment for hospital- acquired Staphylococcus aureus bacteremia. Clin Infect Dis, 2003. 36(11): p. 1418- 23.
54. Peralta, G., et al., Altered blood glucose concentration is associated with risk of death among patients with community-acquired Gram-negative rod bacteremia. BMC Infect Dis, 2010. 10: p. 181.